scholarly article | Q13442814 |
P2093 | author name string | Mohamed A Zayed | |
P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity | Q28072367 | ||
Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
Quantitative Analysis of Lipid-Rich Necrotic Core in Carotid Atherosclerotic Plaques by In Vivo Magnetic Resonance Imaging and Clinical Outcomes. | Q33797900 | ||
Anti-inflammatory therapies for cardiovascular disease | Q34137872 | ||
Cytokines in atherosclerosis: pathogenic and regulatory pathways | Q34511711 | ||
The autoimmune concept of atherosclerosis | Q35550211 | ||
Cardiovascular co-morbidity in rheumatic diseases | Q36835851 | ||
The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus | Q37206876 | ||
Adaptive immunity and atherosclerosis | Q37563746 | ||
The discovery of cellular immunity in the atherosclerotic plaque | Q37619147 | ||
Anti-inflammatory therapeutics for the treatment of atherosclerosis | Q37626768 | ||
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. | Q38404769 | ||
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
The Link Between Inflammatory Disorders and Coronary Heart Disease: a Look at Recent Studies and Novel Drugs in Development | Q38688816 | ||
Dual-energy computed tomography imaging to determine atherosclerotic plaque composition: a prospective study with tissue validation | Q41143090 | ||
C-reactive protein levels and outcomes after statin therapy | Q45213511 | ||
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Q46003173 | ||
New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis. | Q47148282 | ||
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. | Q52312175 | ||
Atherosclerotic Heart Disease in Women With Autoimmune Rheumatologic Inflammatory Conditions. | Q52344283 | ||
Inhibition of cholesterol atherosclerosis by immunisation with beta-lipoprotein. | Q53741016 | ||
Prospective validation of standardized, 3-dimensional, quantitative coronary computed tomographic plaque measurements using radiofrequency backscatter intravascular ultrasound as reference standard in intermediate coronary arterial lesions: results | Q83472030 | ||
IL-1 signalling in atherosclerosis | Q91728284 | ||
Inflammation as a Therapeutic Target in Atherosclerosis | Q92256742 | ||
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia | Q92640056 | ||
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events | Q92980641 | ||
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational Study | Q99414622 | ||
P433 | issue | 9 | |
P921 | main subject | coronary artery disease | Q844935 |
P304 | page(s) | e011451 | |
P577 | publication date | 2020-09-15 | |
P1433 | published in | Circulation: Cardiovascular Imaging | Q3332375 |
P1476 | title | Immune Modulation of Coronary Atherosclerosis With Anticytokine Treatment | |
P478 | volume | 13 |
Search more.